lenalidomide mylan
mylan ireland limited - lenalidomid - szpiczak mnogi - leki immunosupresyjne - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).
lenalidomide krka d.d.
krka, d.d., novo mesto - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - leki immunosupresyjne - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) jest wskazany do leczenia dorosłych pacjentów z wcześniej нелеченной ze szpiczakiem mnogim, którzy nie polega przeszczep. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
thalidomide lipomed
lipomed gmbh - talidomid - szpiczak mnogi - leki immunosupresyjne - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
merional 75 j.m./fiolkę liofilizat i rozpuszczalnik do sporządzania roztworu do wstrzykiwań
ibsa farmaceutici italia s.r.l. - menotropina - liofilizat i rozpuszczalnik do sporządzania roztworu do wstrzykiwań - 75 j.m./fiolkę
gemcitabine hospira 200 mg proszek do sporządzania roztworu do infuzji
hospira uk limited - gemcitabinum - proszek do sporządzania roztworu do infuzji - 200 mg
gemcitabine hospira 2 g proszek do sporządzania roztworu do infuzji
hospira uk limited - gemcitabinum - proszek do sporządzania roztworu do infuzji - 2 g
gemcitabine hospira 1 g proszek do sporządzania roztworu do infuzji
hospira uk limited - gemcitabinum - proszek do sporządzania roztworu do infuzji - 1 g
gemcitabine polpharma 200 mg proszek do sporządzania roztworu do infuzji
zakłady farmaceutyczne polpharma s.a. - gemcitabinum - proszek do sporządzania roztworu do infuzji - 200 mg
gemcitabine polpharma 1 g proszek do sporządzania roztworu do infuzji
zakłady farmaceutyczne polpharma s.a. - gemcitabinum - proszek do sporządzania roztworu do infuzji - 1 g
gemcitabine accord 2 g proszek do sporządzania roztworu do infuzji
accord healthcare polska sp. z o.o. - gemcitabini hydrochloridum - proszek do sporządzania roztworu do infuzji - 2 g